Status:
COMPLETED
Invasive Versus Non-invasive Assessment of Blood Pressure in Hypertensive Disorders of Pregnancy
Lead Sponsor:
Assiut University
Conditions:
Hypertension in Pregnancy
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Hypertensive disorders of pregnancy are important causes of maternal morbidity and mortality worldwide. Hypertension is one of the most commonly reported health conditions among pregnant women and com...
Detailed Description
Study Methods: All patients included in our study were subjected to the following: 1. Full history taking including: Age, full obstetric history including (number of previous pregnancies and abo...
Eligibility Criteria
Inclusion
- All Pregnant women diagnosed to have hypertensive disorders of pregnancy (chronic HTN, gestational HTN, pre-eclampsia or eclampsia) after control of hypertension using anti-hypertensive drugs.
Exclusion
- Patients with previous cardiac diseases.
- Chronic kidney disease (CKD) which is defined as kidney damage or glomerular filtration rate (GFR) \<60 mL/min/1.73 m2 for 3 months or more, irrespective of cause.
- Any disease requiring the use of anti-inflammatory medication, any other endocrine disease such as hyperthyroidism.
- Conditions that prevent invasive blood pressure measurement (arterial cannulation) as severe bleeding disorders.
- Patients refusing to join the study.
- Any associated severe comorbidities have been excluded.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2020
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04303871
Start Date
December 1 2018
End Date
March 5 2020
Last Update
March 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Egypt, 71526